Chaperonin-containing T-complex protein 1 subunit BBS12 (BBS12)

Chaperonin-containing T-complex protein 1 subunit BBS12 (BBS12) is a protein encoded by the BBS12 gene whose mutations are causative for Bardet-Biedl syndrome (BBS), a rare pleiotropic genetic disorder classified as a ciliopathy[1][2][3][4]. BBS12 shows sequence homology to group II chaperonins (especially CCT/TRiC), but lacks canonical ATP-dependent folding activity and does not form regular chaperonin oligomers[1]. Instead, it plays a key role in the early assembly of the BBSome protein complex, stabilizing BBS7 and mediating interactions with canonical CCT chaperonins, which are critical steps in ciliary function and structure[1][2][3]. Mutations in BBS12 account for approximately 8% of BBS cases and are maternally inherited in an autosomal recessive pattern[4]. Patients with BBS12 mutations often manifest severe symptoms, including retinal degeneration, obesity, polydactyly, renal malformations, and cognitive impairment, with notable phenotypic variability even amongst those sharing identical genotypes[1][3][4]. There are currently no approved drugs that directly target BBS12 or its function, and its disease relevance is principally in diagnosis and understanding the pathomechanism of BBS rather than as a classical therapeutic drug target[1].\n\nNotes:\n- BBS12 is not considered a classical drug target such as a receptor or enzyme; rather, it is a genetic disease protein relevant for diagnosis and research in ciliopathies, with no reported direct drug interactions or mechanisms of drug action.\n- BBS12 functions in the context of protein complexes (especially the BBSome and its assembly) rather than as a stand-alone enzyme, receptor, or signaling node.\n- It is important diagnostically: gene mutation status is a biomarker for hereditary Bardet-Biedl syndrome and may influence prognosis[4].

Other names

Bardet-Biedl syndrome 12 proteinC4orf24FLJ35630FLJ41559chaperonin-containing T-complex member BBS12BBS12